On ECHEMI
Home > Drugs > Suzhou Pharmaceutical Factory
Suzhou Pharmaceutical Factory
  • Founded in:

    2006-02-14
  • Country:

    China China
  • Address:

    No. 2-1, Dongwu South Road, Wuzhong District, Suzhou City
  • Tax NO.:

    91320506138170408U
  • Registered Funds:

    -
  • Website:

  • Email:

Related Drugs
Adenosine triphosphate disodium for injection
Chemical name: adenosine-5-triphosphate disodium salt, molecular formula: C10H14N5Na2O13P3 molecular weight: 551.15
Name Description Content CAS NO. Registered Holders
Adenosine5'-(tetrahydrogen triphosphate), disodiuM salt, trihydrate (9CI)

It is a coenzyme that improves the body's metabolism and participates in the metabolism of fat, protein, sugar, nucleic acid and nucleotides in the body. It is also the main source of energy in the body. When energy is needed for absorption, secretion, muscle contraction and biochemical synthesis reactions, adenosine triphosphate is decomposed into adenosine diphosphate and phosphate groups, and energy is released at the same time. Animal experiments can inhibit the slow calcium ion influx of slow-reacting fibers, block or delay the forward conduction in the atrioventricular node reentry pathway, and large doses may also block or delay the forward and reverse conduction of the bypass pathway; in addition, it also has a short-term and strong effect of enhancing the vagus nerve, thereby terminating arrhythmias caused by atrioventricular node reentry and bypass reentry mechanisms.

More

It is a coenzyme that improves the body's metabolism and participates in the metabolism of fat, protein, sugar, nucleic acid and nucleotides in the body. It is also the main source of energy in the body. When energy is needed for absorption, secretion, muscle contraction and biochemical synthesis reactions, adenosine triphosphate is decomposed into adenosine diphosphate and phosphate groups, and energy is released at the same time. Animal experiments can inhibit the slow calcium ion influx of slow-reacting fibers, block or delay the forward conduction in the atrioventricular node reentry pathway, and large doses may also block or delay the forward and reverse conduction of the bypass pathway; in addition, it also has a short-term and strong effect of enhancing the vagus nerve, thereby terminating arrhythmias caused by atrioventricular node reentry and bypass reentry mechanisms.

51963-61-2 0
Lansoprazole for injection
Name Description Content CAS NO. Registered Holders
Lansoprazole

Extract from the above information

More

Extract from the above information

103577-45-3 87
Adefovir Dipivoxil Capsules
The main ingredient of this product is adefovir dipivoxil.
Name Description Content CAS NO. Registered Holders
Adefovir dipivoxil

Chronic toxicity: characterized by tubular nephropathy, with renal toxicity occurring at exposure levels of approximately 3 to 10 times the human therapeutic dose; Genotoxicity: mutagenicity was observed in the in vitro mouse lymphocytoma test, and chromosome aberrations were induced in the human peripheral blood lymphocyte test, but the results of the mouse micronucleus test and the Ames test were negative; Reproductive toxicity: no embryotoxicity or teratogenicity was observed in rat and rabbit tests, but embryotoxicity and fetal malformations occurred in pregnant rats when injected intravenously with high doses; Carcinogenicity: no carcinogenicity was observed in oral tests in mice and rats.

More

Chronic toxicity: characterized by tubular nephropathy, with renal toxicity occurring at exposure levels of approximately 3 to 10 times the human therapeutic dose; Genotoxicity: mutagenicity was observed in the in vitro mouse lymphocytoma test, and chromosome aberrations were induced in the human peripheral blood lymphocyte test, but the results of the mouse micronucleus test and the Ames test were negative; Reproductive toxicity: no embryotoxicity or teratogenicity was observed in rat and rabbit tests, but embryotoxicity and fetal malformations occurred in pregnant rats when injected intravenously with high doses; Carcinogenicity: no carcinogenicity was observed in oral tests in mice and rats.

142340-99-6 27
Adefovir dipivoxil
Name Description Content CAS NO. Registered Holders
Adefovir dipivoxil

Extract from the above information

More

Extract from the above information

142340-99-6 27
Carbazochrome Sodium Sulfonate
Name Description Content CAS NO. Registered Holders
Carbazochrome sodium sulfonate

Extract from the above information

More

Extract from the above information

51460-26-5 33
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.